Category: Products
Mislabelled products: legal rights for compensation
Anyone who has been harmed as a result of mislabelled products could be entitled to bring a claim for compensation, and we can offer No Win, No Fee legal representation for eligible clients.
As Group Action Lawyers, this is the kind of event that we can represent people for. Not all incidents of the incorrect information on products can lead to harm but, when it does, this is where we may be able to help anyone affected.
Preventing medical implant problems is key for the future
It may sound obvious when we talk about the importance of preventing medical implant problems before mass scandals occur, but it is a key point to raise given our line of work.
As specialist Group Action Lawyers, we have represented thousands of people engaged in group and multi-party actions. Some of those have been for medical implant scandals, including the PIP Breast Implant Scandal, the Vaginal and Hernia Mesh issues, and the Metal-On-Metal Hip Implant cases. What this means is that we have seen first-hand just how badly patients can suffer when things go wrong, and we do not want to see a repeat of such scandals and the awful consequences that ensue. Whilst it can be difficult to prevent problems like the PIP Breast Implant cases where deceit was involved, preventing medical implant scandals through better testing and warnings is a development to push forward with.
It is easy to look back in hindsight and see what could have been done differently. But it is important to look to the future to make sure that there are no repeats of mistakes that could have been prevented.
Cyberattacks targeting medical devices: a cause for concern?
The idea of cyberattacks targeting medical devices is not so much a theory nowadays, but more of a real cause for concern that needs to be addressed.
As specialist Group Action Lawyers, we are used to seeing the harm caused to real people when things go wrong on a large scale. Whilst we are always here to help, prevention is always better than having to deal with the aftermath. As such, hacks and how they apply to an increasingly digitised world is something that we all need to be wary of; especially when it comes to the healthcare sector.
Sterility problems and compensation actions
Anyone who has been adversely affected by sterility problems could be entitled to pursue a claim for personal injury compensation on a No Win, No Fee basis.
As a firm of specialist Group Action Lawyers, we have represented many victims for issues concerning the sterility of equipment and devices, and there have been plenty of regulatory recalls over the years where this has been the issue.
A single event or a prolonged problem where an issue over sterility occurs could lead to thousands of people being put at risk. Anyone who has ever suffered harm in this way could be entitled to pursue a claim for damages.
The wider importance of our emissions actions
Our emissions actions now number at over 30 in terms of the number of carmakers that we are taking legal cases forward for, representing thousands of people on a No Win, No Fee basis.
Whilst action for justice for the consumers is important and is an integral part of what we are doing, it is also incredibly important to recognise the wider importance of the action that we are taking. It is about punishments and deterrents and, given the impact that cheating emissions can have on human health and on our environment, our work is vital.
Compensation for medicine recalls
You can be entitled to claim compensation for medicine recalls if you have suffered some form of harm or injury arising from an issue with medicines that you have taken.
If something has gone wrong and the fault lies with the manufacturer, seller, or even someone administering medicine, you could be entitled to pursue a legal case. We can offer No Win, No Fee legal representation, and you can speak to the team here for free, no-obligation advice.
Eye injury group action claims for compensation
Eye injury group action cases can mean representing some of the most seriously injured people there can be when this vital sense is harmed or adversely affected by a problem.
We have, and still do, represent people claiming in group/multi-party cases for eye injury claims. If you need advice about an ongoing action, or about a potential new action, we are always happy to hear from you.
You can speak to the team for free, no-obligation advice here now.
The priority of protecting consumers from unsafe products
Protecting consumers from unsafe products must always be seen as an absolute priority in the UK and, indeed, around the world.
This is why we were keen to see the results of a recent parliamentary publication. This publication has highlighted a number of flaws and matters to be addressed to ensure that the public is properly protected from harm. We will take a brief look at the headings in terms of the areas of concern, and give our expert take on things.
In terms of action for justice, we remind people that we can represent victims of harm caused by products on a No Win, No Fee basis.
Medoject hypodermic and blunt fill needles
An update has recently been issued by the MHRA (Medicines and Healthcare products Regulatory Agency) warning of the potential dangers of Medoject hypodermic and blunt fill needles produced by the manufacturer. After concerns were raised about certain batches, the manufacturer issued a Field Safety Notice recalling the five batches of needles in question, according to the MHRA. Used by healthcare services across the UK, there is a worry that a potentially harmful substance may have been unknowingly injected into patients.
Over the years, we have taken on a number of claims regarding faulty or harmful medical products, including hernia mesh and metal-on-metal hip implants. One of our biggest group litigation cases is that of the PIP breast implants – in our action, we have already recovered over £1m in compensation for the victims.
Although there is currently no evidence to suggest that anyone has been harmed by the Medoject needles, we believe that all cases like these require thorough investigation.
MHRA raises alert regarding potential “incomplete sterilisation” – Steril Milano
The Medicines and Healthcare products Regulatory Agency (MHRA), the UK government regulator that monitors the practices of medical product manufacturers and the safety of the goods they produce, has reportedly identified fraudulent activity involving a company based in Italy. Steril Milano is understood to provide services for sterilising medical equipment and devices for a number of manufacturers, including some who supply products to the UK.
However, following its acquisition by a new parent company in 2021, it is believed that Steril Milano did not complete sterilisation processes to the required standard for dozens of manufacturers to whom it provides its services. In response, according to the MHRA, they were forced to take action to ensure that the risk to patients in the UK is minimised.
Whenever concerns are raised about the safety of medical products, it is essential that regulators act to investigate the manufacturers suspected of negligence, as well as alerting relevant hospitals and healthcare centres to give them an opportunity to protect their patients. The MHRA has hopefully acted quickly enough in this case to prevent as many patients as possible from being harmed.